80 likes | 99 Views
Rapid Tests Market was valued at $21,455 million in 2016, and is expected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023.<br><br>
E N D
Introduction • Rapid Tests market was valued at $21,455 million in 2016, and is expected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. • Rapid tests provide diagnostic results spontaneously to patients and are preferably used in preliminary screenings as well as and in settings with limited resources. • Factors such as increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and the need for low-cost diagnostic testing coupled with diagnosis accuracy are expected to boost the growth of the rapid tests market during the forecast period. • The global rapid tests market is segmented based on product, application, end user, and region. Based on products, the market is bifurcated as over-the-counter (OTC) rapid test product and professional rapid test product.
Key Findings of theMarket • Based on product, the over-the-counter (OTC) rapid test product segment is expected to show the fastest growth, from 2017 to 2023. • Based on application, the glucose monitoring segment held approximately half of the global market share in 2016 and is expected to remain dominant throughout the forecast period. • Based on application, the infectious disease segment exhibited double digit growth rate. • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 10.5% during the forecast period.
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. • It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities. • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities. • The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market. Key Benefits Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/4633
By Product Type • Over-the-counter (OTC) Rapid Test Product • Professional Rapid Test Product • By Application • Infectious Disease • HPV • Hepatitis • Influenza • Malaria • HIV • Others • Cardiology • Oncology • Pregnancy & Fertility • Toxicology • Glucose Monitoring • Others MarketSegmentation • By End User • Hospital & Clinic • Diagnostic Laboratory • Home Care • Others • By Region • North America • Europe • Asia-Pacific • LAMEA
Akers Biosciences, Inc., • AlereInc. (Abbott Laboratories), • Becton, • Dickinson and Company, • Bio-radLaboratories, Inc., • Cepheid, Inc., • Others Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/4633
About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch
ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/rapid-tests-market Follow UsOn: